Essential role for neutrophils but not alveolar macrophages at early time points following aspergillus fumigatus infection

Journal of Infectious Diseases

Volumn 200, Issue 4, 2009, Pages 647-656

  Mircescu, Monica M ^a   Lipuma, Lauren ^a   Van Rooijen, Nico ^b   Pamer, Eric G ^a   Hohl, Tobias M ^a,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CELL FUNCTION; CELL INVASION; CELL POPULATION; CELL SURVIVAL; CONIDIUM; CONTROLLED STUDY; DEPLETION; FUNGUS HYPHAE; FUNGUS SPORE; GERMINATION; HOST RESISTANCE; INHALATION; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SURVIVAL RATE; ANIMAL; C57BL MOUSE; CYTOLOGY; IMMUNOLOGY; LUNG; LUNG ASPERGILLOSIS; MICROBIOLOGY; PHYSIOLOGY; TIME;

ANIMALS; ASPERGILLUS FUMIGATUS; LUNG; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C57BL; NEUTROPHILS; PULMONARY ASPERGILLOSIS; TIME FACTORS;

EID: 69149089714     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/600380     Document Type: Article

References (49)

1. Denning DW Invasive aspergillosis. Clin Infect Dis 1998;26:781-803.
2. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999;12:310-350
3. McNeil MM, Nash SL, Hajjeh RA, et al. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis 2001;33:641-647
4. Hohl TM, Feldmesser M. Aspergillus fumigatus: principles of pathogenesis and host defense. Eukaryot Cell 2007;6:1953-1963
5. Young RC, Bennett JE, Vogel CL, Carbone PP, DeVita VT. Aspergillosis: the spectrum of the disease in 98 patients. Medicine 1970;49:147-173
6. 6. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984;100:345-351 (Pubitemid 14156535)
7. Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus: observations on these 2 lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest 1982;69:617-631
8. Merkow L, Pardo M, Epstein SM, Verney E, Sidransky H. Lysosomal stability during phagocytosis of Aspergillus flavus spores by alveolar macrophages of cortisone-treated mice. Science 1968; 160:79-81.
9. Waldorf AR, Levitz SM, Diamond RD. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J Infect Dis 1984; 150:752-760
10. 10. Schaffner A. Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. J Clin Invest 1985; 76: 1755-1764 (Pubitemid 16196042)
11. Philippe B, Ibrahim-Granet O, Prevost MC, et al. Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infect Immun 2003;71:3034-3042
12. Diamond RD, Clark RA. Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro. Infect Immun 1982;38:487-495
13. Rehm SR, Gross GN, Hart DA, Pierce AK. Animal model of neutropenia suitable for the study of dual-phagocyte systems. Infect Immun 1979;25:299-303.
14. 14. Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci 1998;94:557-572 (Pubitemid 28269054)
15. Morgenstern DE, Gifford MA, Li LL, Doerschuk CM, Dinauer MC. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J Exp Med 1997; 185:207-218
16. 16. Garlanda C, Hirsch E, Bozza S, et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 2002; 420:182-6. 17. Bonnett CR, Cornish EJ, Harmsen AG, Burritt JB. Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus conidia. Infect Immun 2006; 74:6528-6539 (Pubitemid 35340122)
17. Mehrad B, Strieter RM, Moore TA, Tsai WC, Lira SA, Standiford TJ. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis. J Immunol 1999; 163:6086-6094
18. 19. Stephens-Romero SD, Mednick AJ, Feldmesser M. The pathogenesis of fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion strategy. Infect Immun 2005;73:114-125 (Pubitemid 40041101)
19. 20. Morrison BE, Park SJ, Mooney JM, Mehrad B. Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J Clin Invest 2003; 112:1862-1870 (Pubitemid 38063709)
20. Hohl TM, Van Epps HL, Rivera A, et al. Aspergillus fumigatus triggers inflammatory responses by stage-specific β-glucan display. PLoS Pathog 2005; 1:e30.
21. Steele C, Rapaka RR, Metz A, et al. The β-glucan receptor dectin-1 recognizes specific morphologies oí Aspergillus fumigatus. PLoS Pathog 2005; 1:e42.
22. Cornish EJ, Hurtgen BJ, McInnemey K, et al. Reduced nicotinamide adenine dinucleotide phosphate oxidase-independent resistance to Aspergillus fumigatus in alveolar macrophages. J Immunol 2008; 180: 6854-6867
23. 24. Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 1994; 174:83-93. (Pubitemid 24297139)
24. Hestdal K, Ruscetti FW, Ihle JN, et al. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J Immunol 1991; 147:22-28
25. 26. Thepen T, Van Rooijen N, Kraal G. Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J Exp Med 1989; 170:499-509. (Pubitemid 19204277)
26. 27. Shao X, Mednick A, Alvarez M, van Rooijen N, Casadevall A, Goldman DL. An innate immune system cell is a major determinant of speciesrelated susceptibility differences to fungal pneumonia. J Immunol 2005;175:3244-3251 (Pubitemid 41170545)
27. 28. Sung SS, Fu SM, Rose CE Jr, Gaskin F, Ju ST, Beaty SR. A major lung CD103 (αE)-β7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J Immunol 2006; 176: 2161-2172 (Pubitemid 43201663)
28. 29. Mehrad B, Strieter RM, Standiford TJ. Role of TNF-a in pulmonary host defense in murine invasive aspergillosis. J Immunol 1999; 162: 1633-1640 (Pubitemid 29307039)
29. 30. Warris A, Bjorneklett A, Gaustad P. Invasive pulmonary aspergillosis associated with infliximab therapy. N Engl J Med 2001; 344:1099-1100 (Pubitemid 32267986)
30. 31. Roilides E, Uhlig K, Venzon D, Pizzo PA, Walsh TJ. Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and γ interferon. Infect Immun 1993;61:1185-1193 (Pubitemid 23099183)
31. Taramelli D, Malabarba MG, Sala G, Basilico N, Cocuzza G. Production of cytokines by alveolar and peritoneal macrophages stimulated by Aspergillus fumigatus conidia or hyphae. J Med Vet Mycol 1996; 34: 49-56.
32. Gersuk GM, Underhill DM, Zhu L, Marr KA. Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states. J Immunol 2006; 176:3717-3724
33. Brieland JK, Jackson C, Menzel F, et al. Cytokine networking in lungs of immunocompetent mice in response to inhaled Aspergillus fumigatus. Infect Immun 2001;69:1554-1560
34. 35. Thakur ML, Li J, Chandy B, John EK, Gibbons G. Transient neutropenia: neutrophil distribution and replacement. J Nucl Med 1996; 37: 489-494 (Pubitemid 26094280)
35. Broug-Holub E, Toews GB, van Iwaarden JF, et al. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. Infect Immun 1997;65:1139-46.
36. Cheung DO, Halsey K, Speert DP. Role of pulmonary alveolar macrophages in defense of the lung against Pseudomonas aeruginosa. Infect Immun 2000;68:4585-4592
37. Filler SG, Sheppard DC. Fungal invasion of normally non-phagocytic host cells. PLoS Pathog 2006;2:e129.
38. Botterel F, Gross K, Ibrahim-Granet O, et al. Phagocytosis of Aspergillus fumigatus conidia by primary nasal epithelial cells in vitro. BMC Microbiol 2008; 8:97.
39. Chiang LY, Sheppard DC, Gravelat FN, Patterson TF, Filler SG. Aspergillus fumigatus stimulates leukocyte adhesion molecules and cytokine production by endothelial cells in vitro and during invasive pulmonary disease. Infect Immun 2008; 76:3429-3438
40. 41. Phadke AP, Akangire G, Park SJ, Lira SA, Mehrad B. The role of CC chemokine receptor 6 in host defense in a model of invasive pulmonary aspergillosis. Am J Respir Crit Care Med 2007; 175:1165-1172 (Pubitemid 46855458)
41. Chignard M, Balloy V, Sallenave JM, Si-Tahar M. Role of Toll-like receptors in lung innate defense against invasive aspergillosis. Distinct impact in immunocompetent and immunocompromized hosts. Clin Immunol 2007; 124:238-243
42. 43. Maus UA, Janzen S, Wall G, et al. Resident alveolar macrophages are replaced by recruited monocytes in response to endotoxin-induced lung inflammation. Am J Respir Cell Mol Biol 2006; 35:227-235 (Pubitemid 44175323)
43. Zarember KA, Sugui JA, Chang YC, Kwon-Chung KJ, Gallin JI. Human polymorphonuclear leukocytes inhibit Aspergillus fumigatus conidial growth by lactoferrin-mediated iron depletion. J Immunol 2007; 178: 6367-6373
44. 45. Jaillon S, Peri G, Delneste Y, et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med 2007;204:793-804. (Pubitemid 46631609)
45. Quails JE, Kaplan AM, van Rooijen N, Cohen DA. Suppression of experimental colitis by intestinal mononuclear phagocytes. J Leukoc Biol 2006;80:802-815
46. Koh AY, Kohler JR, Coggshall KT, Van Rooijen N, Pier GB. Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog 2008; 4:e35.
47. Nawada R, Amitani R, Tanaka E, et al. Murine model of invasive pulmonary aspergillosis following an earlier stage, noninvasive Aspergillus infection. J Clin Microbiol 1996;34:1433-1439
48. 49. Offner F, Cordonnier C, Ljungman P, et al. Impact of previous aspergillosis on the outcome of bone marrow transplantation. Clin Infect Dis 1998;26:1098-1103 (Pubitemid 28215472)
49. 50. Fukuda T, Boeckh M, Guthrie KA, et al. Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center. Biol Blood Marrow Transplant 2004; 10: 494-503. (Pubitemid 38772003)